FCA CORP /TX - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
FCA CORP /TX ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$370,0000.0%8,5000.0%0.15%
+13.2%
Q1 2022$370,000
-1.3%
8,5000.0%0.13%
+0.8%
Q4 2021$375,000
+6.8%
8,5000.0%0.13%
+20.8%
Q3 2021$351,000
+3.8%
8,5000.0%0.11%
+10.4%
Q2 2021$338,000
+11.2%
8,5000.0%0.10%
+7.9%
Q1 2021$304,000
-2.9%
8,5000.0%0.09%
-11.0%
Q4 2020$313,000
-9.8%
8,5000.0%0.10%
-24.2%
Q2 2020$347,000
+7.8%
8,5000.0%0.13%
-6.4%
Q1 2020$322,000
-19.3%
8,5000.0%0.14%
+2.2%
Q4 2019$399,000
+9.9%
8,5000.0%0.14%
+2.2%
Q3 2019$363,000
+6.8%
8,5000.0%0.14%
+8.9%
Q2 2019$340,000
+25.0%
8,500
+30.8%
0.12%
+17.0%
Q1 2019$272,000
+9.7%
6,5000.0%0.11%
-5.4%
Q4 2018$248,000
-5.0%
6,5000.0%0.11%
+12.0%
Q3 2018$261,000
-0.4%
6,5000.0%0.10%
-3.8%
Q2 2018$262,000
+3.1%
6,5000.0%0.10%0.0%
Q1 2018$254,000
+10.0%
6,5000.0%0.10%
+13.0%
Q4 2017$231,000
-12.5%
6,5000.0%0.09%
-15.6%
Q3 2017$264,000
-5.7%
6,5000.0%0.11%
-10.7%
Q2 2017$280,000
+2.2%
6,5000.0%0.12%
-5.4%
Q1 2017$274,000
+9.6%
6,5000.0%0.13%
+4.0%
Q4 2016$250,000
-11.3%
6,5000.0%0.12%
-13.9%
Q2 2016$282,000
+26.5%
6,500
+18.2%
0.14%
+22.0%
Q1 2016$223,0005,5000.12%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders